Leef Brands Clears 81.6 Million Shares for Resale as Vertical Push Lifts Margins
The California concentrate maker carries substantial-doubt going-concern language even as its second-half gross margin jumped to 41 percent.
July 10, 2026

Cannabis concentrate producer Leef Brands has registered roughly 81.6 million of its common shares for resale, opening a path for early investors and affiliated funds to sell into the public market without the company itself raising new equity from the transaction.
The registration covers 81,555,686 shares tied to selling security holders: about 49.1 million shares already outstanding and another 32.5 million issuable when outstanding purchase warrants are exercised. Leef will collect nothing from the resales themselves. Its only potential cash from the arrangement would arrive if warrant holders pay to exercise — an event that would bring in about $7.0 million. The company bears the registration costs; the sellers bear any sale commissions.
An insider-weighted exit
For a small, thinly traded operator, the mechanics matter less than who is being handed liquidity. The share block leans toward insiders and recent financing participants:
- The Mindset entities — Mindset Leef, Mindset Value Fund and Mindset Value Wellness Fund — together hold more than 5 percent of Leef and rank as affiliates.
- Board member Robert Mendola is among the holders and acted as the seller representative in Leef’s April acquisition of Standard Holdings.
Leef entered into no registration-rights agreement obligating this step; it elected to register the private-placement and warrant shares on its own initiative, a discretionary move that chiefly benefits those holders’ ability to exit.
A vertical-integration bet
The registration lands against a business reshaping itself into a vertically integrated supplier. Leef is a British Columbia–incorporated company operating in California, producing bulk cannabis concentrates — distillate, hydrocarbon and solventless extracts — for other brands across California and New York. Its shares trade on the Canadian Securities Exchange as LEEF and on the OTCQB as LEEEF, last reported at $0.198 on July 2.
The centerpiece is Salisbury Canyon Ranch, a 1,900-acre Santa Barbara County property acquired in 2023. Leef planted an initial 57 acres in 2025 and holds a permit for 179.9 acres, which it expects to build out fully by fall 2026 and plant across the whole footprint in 2027. Bringing biomass in-house is the lever management is pulling to counter the price compression that has hollowed out California wholesale margins. On the extraction side, Leef says its closed-loop facilities can produce more than one million pounds of concentrate annually after early-2025 capacity expansions across all three lines.
Improving operations, strained balance sheet
The strategy is beginning to register in the numbers. Revenue rose 22 percent in 2025 to $34.8 million, from $28.5 million, helped by higher business-to-business volume and an entry into New York late in the third quarter under a Type 1 processor license. Bulk concentrate sales to California and New York brands accounted for $31.3 million of that total. Gross margin widened to 30 percent from 27 percent, and the second half reached 41 percent as ranch-grown biomass displaced third-party supply. The net loss narrowed sharply to $17.6 million from $24.6 million — though the improvement leaned heavily on non-cash swings in debt-extinguishment and derivative-liability values rather than on operations alone.
Those gains sit alongside a fragile financial position. Leef closed 2025 with:
- $2.2 million in cash
- An accumulated deficit of $139.4 million
- A stockholders’ deficit of $8.3 million
- A small working-capital deficit
Management states plainly that it must raise capital immediately to fund operations and meet obligations, and that these conditions create substantial doubt about the company’s ability to continue as a going concern over the coming year. Leef has relied on related parties for debt funding and offers no assurance that financing will be available on acceptable terms. It has never paid a common dividend and does not intend to while its preferred stock is outstanding.
A crowded capital structure
That preferred stock is a recent addition. In March 2026, Leef closed a private placement of Series A-1 preferred shares, issued at CAD $0.38 apiece and carrying a cumulative 15 percent annual dividend — two-thirds in cash, one-third in additional shares. The tranche formed part of a roughly $4.5 million financing led by Mindset Capital, the same sponsor group now positioned to sell common stock under the resale registration. About 11.2 million preferred shares are outstanding, and their dividend claims rank ahead of the common.
The common count has swelled through debt restructuring. In December 2025, Leef converted convertible debentures into just over 60 million shares plus an equal number of three-year warrants struck at CAD $0.30. Combined with continuing private placements, that lifted shares outstanding to about 305.4 million as of mid-June, with tens of millions more issuable under warrants at a weighted-average exercise price of $0.23. For a stock near 20 cents, the overhang is substantial, and the resale registration adds another tranche holders can now sell.
Leef is also growing by acquisition. In April it completed the purchase of Standard Holdings, parent of the HIMALAYA Vapor brand, adding full-spectrum cartridges and an established Northern California customer base. Management frames consolidation and distressed-asset opportunities as central to its plan, alongside the longer-term prospect of federal rescheduling and banking reform unlocking institutional capital for the sector.
The through-line is a company betting that owning its supply chain will let it survive a punishing California market long enough to reach scale — while giving its backers a registered exit in the meantime. Whether the margin trajectory holds as cultivation ramps, and whether Leef can secure the capital its own auditors flag as urgently needed, will determine how much of the thesis translates into value for common holders rather than for the preferred and warrant claims stacked ahead of them.